the New England Section of the American Urological Association
Search Meeting Site Only
Annual Meeting Home
Past & Future Meetings: NEAUA

Back to 2011 Program

VED Registry In Men Treated For Prostate Cancer: Initial Results Of A Prospective, Multi-institutional Dataset.
Edouard J Trabulsi1, John C Rewcastle2, Gerry Brock3, Craig Donatucci4, Run Wang5, John Mulhall6
1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA;2University of Southern California, Los Angeles, CA;3University of Western Ontario, London, ON, Canada4Duke University, Durham, NC;5University of Texas Medical School at Houston, Houston, TX;6Memorial Sloan-Kettering Cancer Center, New York, NY

Introduction: The VED Registry is an IRB approved prospective multicenter database for men prescribed a Vacuum Erection Device (VED). We report initial data collected from men who have undergone prostate cancer (PCa) treatment.
Materials & Methods: Patients were sent questionnaires to be completed and returned at the time of receipt of the VED and at 3, 6 and 12 months. Baseline questionnaires consisted of a brief history including information on (PCa) diagnosis and treatment (Tx), the IIEF and an ED treatment inventory. Follow-up questionnaires included the full IIEF, ED treatment inventory and a VED questionnaire. Only PCa patients are included in this analysis.
Results: In 12 months 395 questionnaires were returned 210 from PCa patients. Baseline SHIM scores are summarized in the table; note that some men were unsure of their treatment details. Similar dissatisfactions (scale: 1-5) were observed for post prostatectomy rehabilitation with Viagra (1.0+0.9), Levitra (2.0+1.0) and Cialis (1.7+0.0). The 3-month dataset is small and analysis is premature. However it was noted that VED satisfaction score was 2.0+1.4 and 45.0% of 22 patients reported an increase in the length of their erect penis at 3-months.
The data is embryonic but the ability to collect large amounts of patient data has been demonstrated and it is anticipated the VED Registry will contribute significantly to post prostatectomy ED knowledge. Supported by Firma Medical Co.

Baseline SHIM Scores
All (n)Full Gland (n)Unilateral NS (n)Bilateral NS (n)Focal (n)
Prostatectomy (all)8.9+9.6 (131)11.6+10.4 (32)11.6+9.0 (7)9.4+10.3 (50) -
Robotic/Lap8.8+9.4 (107)11.7+10.6 (21)9.3+7.4 (6)8.9+10.3 (45) -
Open9.5+10.4 (24)11.4+10.5 (11)25+N/A (1)14.0+10.8 (5) -
Radiation (all)13.4+8.3 (23) - - - -
Cryoablation3.1+6.7 (28)3.2+6.9 (14) (0) (0) 2.5+6.1 (6)

Back to 2011 Program


© 2024 New England Section of the American Urological Association. All Rights Reserved. Privacy Policy.